Clinical trial
Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV…
NCT00002157 · Celgene Corporation, Industry · Completed
Key facts
| NCT number | NCT00002157 |
|---|---|
| Title | Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome |
| Official title | Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome |
| Lead sponsor | Celgene Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Wasting Syndrome |
| Intervention type | Drug |
| Interventions | Thalidomide |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: